FDA clears Ventris Medical Amplify standalone bone graft putty

Ventris Medical recently received FDA 510(k) clearance for its Amplify standalone bone graft putty in the intervertebral disc space.

The Newport Beach, California-based company designed Amplify to optimize cell proliferation and bone formation. It comprises the Amplify biphasic (HA-to-βTCP) ceramic granules suspended in an alkaline oxide polymer carrier. It can be used standalone or combined with autograft bone as a bone graft extender.

“We are very pleased to receive FDA clearance for Amplify Synthetic Bone Graft Putty for the intervertebral disc space. This technology combines 2 heavily studied biphasic mineral components, which are surface activated through our patented process and suspended in our proprietary polymer carrier,” CEO Russell Cook said in a news release. In a market crowded with a plethora of commodity offerings, our company mission is to develop next-generational devices that bring excitement to the surgeon community as well as our…

Read more
  • 0